Immatics (IMTX) Selling, General & Administrative (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | -15.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.91 Mn |
| Sep 30, 2025 | -14.82 Mn |
| Jun 30, 2025 | -14.47 Mn |
| Mar 31, 2025 | -12.69 Mn |
| Dec 31, 2024 | -14.45 Mn |
| Sep 30, 2024 | -12.25 Mn |
| Jun 30, 2024 | -10.91 Mn |
| Mar 31, 2024 | -12.65 Mn |
| Dec 31, 2023 | -11.16 Mn |
| Sep 30, 2023 | -9.67 Mn |
| Jun 30, 2023 | -10.19 Mn |
| Mar 31, 2023 | -10.29 Mn |
| Dec 31, 2022 | -9.94 Mn |
| Sep 30, 2022 | -8.49 Mn |
| Jun 30, 2022 | -9.27 Mn |
| Mar 31, 2022 | -10.41 Mn |
| Dec 31, 2021 | -10.11 Mn |
| Sep 30, 2021 | -9.75 Mn |
| Jun 30, 2021 | -9.96 Mn |
| Mar 31, 2021 | -10.17 Mn |
| Dec 31, 2020 | -10.37 Mn |
| Sep 30, 2020 | -10.76 Mn |
| Jun 30, 2020 | -11.10 Mn |
| Mar 31, 2020 | -6.83 Mn |
| Dec 31, 2019 | -5.10 Mn |
| Sep 30, 2019 | -3.08 Mn |
| Jun 30, 2019 | -2.36 Mn |